Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Outlook Therapeutics
Biosimilars
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
B2X
B2B
0
CEO
Russell Trenary III
0
CIK Number
1,649,989
0
Legal Name
Outlook Therapeutics, Inc.
0
Company Operating Status
Active
Country
United States
Crunchbase URL
crunchbase.com/organiz...iologics
Email Address
info@outlooktherapeutics.com
0
Full Address
485 Route 1 South, Building F, Suite 320, Iselin, NJ 08830, USA
0
Industry
Technology
Biosimilar
Engineering
Biomedical engineering
Biology
Biotechnology
Investors
venBio
IRS Number
383,982,704
0
Latest Funding Round Date
February 2021
Latest Funding Round Amount (USD)
4,013,627
Legal classification
Corporation
Public company
0
LinkedIn URL
@company/outlook-therapeutics
Location
Monmouth Junction, New Jersey
Iselin, New Jersey
0
Number of Employees
9
0
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
2
Phone Number
+16096193990
0
Pitchbook URL
pitchbook.com/profiles.../65006-29
Place of Incorporation
Delaware
0
Previous Name
Oncobiologics, Inc.
0
SIC Code
2,836
0
Exchange
Nasdaq
Stock Symbol
OTLK
0
Ticker Symbol
OTLK
0
Total Funding Amount (USD)
20,013,627
Twitter URL
@outlooktx
Official Website
outlooktherapeutics.com
Find more companies like Outlook Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE